Hilleman Laboratories is committed to developing high impact, affordable vaccines for people in developing countries in an innovative and sustainable manner.

Hilleman Laboratories announces strategic collaboration with Gotovax AB to

Date: 17/06/2014

Tiered pricing strategy to increase access to vaccines (World Immunisation

Date: 25/04/2014

MSD Wellcome Trust Hilleman Laboratories Appoints Gerd Zettlmeissl And Gord

Date: 20/11/2013

Appointment of new Hilleman CEO Davinder Gill

Date: 06/01/2012

Making New Vaccines Affordable

Date: 01/01/2012

Jamia Hamdard Launches Vaccinology Initiative

Date: 01/09/2011

Hilleman Laboratories Collaborating for Success

Date: 16/07/2011

Hilleman's R&D Centre in Delhi

Date: 13/07/2011

Hilleman's R&D Centre in Delhi - Chennai

Date: 13/07/2011

New Experiment for Vaccine Research Development

Date: 09/05/2011

Working Towards Affordable Care

Date: 05/02/2011

Wellcome, Merck JV to Make Anti-Diarrhea Vaccine for Babies

Date: 25/01/2011

Programme in Vaccinology

Date: 25/01/2011

Merck JV Looking at New Rotavirus Vaccine for Poor

Date: 25/01/2011

Merck to Fund Rotavirus Vaccine Project

Date: 25/01/2011